(Page 2 of 2)
private network of telepharmacists and software-as-a-service to help hospitals provide cost-efficient pharmacy services.
—San Diego’s Cardium Therapeutics, which trades over the counter under the ticker symbol CRXM, said it has changed its name to Taxus Cardium Pharmaceuticals in a strategic collaboration with China-based Shanxi Taxus Pharmaceuticals. Under the deal, Shanxi Taxus agreed to invest as much as $5 million in Cardium.
—San Diego-based Trovagene (NASDAQ: TROV) said it entered into a strategic partnership with the Catholic Health Initiatives Center for Translational Research to determine the effectiveness of Trovagene’s urine-based cell-free DNA diagnostic technology as a tool for measuring the effectiveness of cancer treatments. Trovagene said the ability to non-invasively track how much benefit a patient receives through the course of his treatment could shape how oncology care is delivered. The Catholic Health Initiatives, based in suburban Denver, CO, comprises 87 hospitals in 18 states.
—San Diego’s Daylight Solutions, which specializes in mid-infrared laser technologies, introduced a new product—a commercial laser-based infrared microscope. In a statement, the company said its technology opens new biomedical research possibilities with chemical imaging and analysis on a real-time basis, enabling researchers to observe micron-scale features in a wide-field view.